Theodore Lawrence MD FASTRO FASCO
Central Nervous System Cancer, Gastrointestinal Cancer, Sarcoma
Professor Department of Radiation Oncology University of Michigan
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Fax+1 734-763-7371
Dr. Lawrence is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1986
Weill Cornell MedicineClass of 1980
Certifications & Licensure
MI State Medical License 1987 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
American Board of Radiology Radiation Oncology
American Board of Internal MedicineAmerican Board of Internal Medicine- American Board of Internal MedicineMedical Oncology
Publications & Presentations
PubMed
- H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition.Yupei Guo, Zian Li, Leslie A Parsels, Zhuwen Wang, Joshua D Parsels
Neuro-Oncology. 2025-04-10 - Assessing the Relationship Between MR-Based Functional Dose Metrics and Post-Stereotactic Body Radiation Therapy Albumin-Bilirubin Change.Lise Wei, Madhava P Aryal, John Rice, Joseph Evans, Kyle Cuneo
International Journal of Radiation Oncology, Biology, Physics. 2025-03-31 - Erratum to: Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Yanagihara TK, Tepper J...Ted K Yanagihara, Joel E Tepper, Andrew M Moon, Aisling Barry, Meritxell Molla
Practical Radiation Oncology. 2025-03-28
Journal Articles
- No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine KinasesDaniel R Wahl, Theodore S Lawrence, Clinical Cancer Research
- Effectiveness and Cost of Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Early‐Stage Hepatocellular Carcinoma: An Analysis of SEER‐MedicareAmit G Singal, Neehar D Parikh, Theodore S Lawrence, Nataliya Razumilava, Journal of Medical Imaging and Radiation Oncology
- A Multi‐Objective Bayesian Networks Approach for Joint Prediction of Tumor Local Control and Radiation Pneumonitis in Non‐Small‐Cell Lung Cancer (NSCLC) for Response‐A...Theodore S Lawrence, Martha M Matuszak, Shruti Jolly, Medical Physics
Press Mentions
Sixteen Individuals, and Members of Comprehensive Stroke Program, Honored with Faculty and Staff AwardsDecember 13th, 2024- What Is Liver Cancer? Symptoms, Causes, Diagnosis, Treatment, and PreventionJune 12th, 2022
- $30M Gift to Establish the Ronald Weiser Center for Prostate Cancer at Michigan MedicineDecember 15th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
